Find a Physician

Return to Pulmonary Hypertension Center Overview

Clinical Services

Return to Pulmonary Hypertension Center Overview

Health Information

Return to Pulmonary Hypertension Center Overview

Research and Clinical Trials

Return to Pulmonary Hypertension Center Overview

For Patients, Families & Visitors

Return to Pulmonary Hypertension Center Overview

Professionals

Return to Pulmonary Hypertension Center Overview

Hospital News

Return to Pulmonary Hypertension Center Overview

Cardiology

Pulmonary Hypertension Center

Erika Berman Rosenzweig, MD, Director

Pulmonary hypertension is a serious condition which can occur at any age and affects the smallest blood vessels in the lungs leading to right heart failure if left untreated. At the Center, we treat idiopathic (primary) pulmonary hypertension and pulmonary hypertension associated with a variety of conditions including:

• congenital heart disease
• genetic (familial)
• scleroderma
• lupus
• clotting disorders
• pulmonary hypertension of the newborn
• chronic lung disease
• HIV disease
• sickle cell disease
• toxins

Patients and their families who are facing this challenging condition can be assured of receiving state-of-the-art care at our Pulmonary Hypertension Center. In addition to patient care, research and education are a major focus at our Pulmonary Hypertension Center.

We remain on the forefront of research in the field. In fact, our Center has participated in most of the clinical drug trials to date for the development of new medical treatments for pulmonary hypertension, including the first drug approved for treatment of this condition in 1995.

Today, new therapies, including prostanoids (epoprostenol, treprostinil, iloprost), endothelin receptor antagonists (ambrisentan, bosentan), and phosphodiesterase 5-inhibitors (sildenafil), have dramatically improved quality of life and long-term outcome for patients living with pulmonary hypertension. The pulmonary hypertension research team is currently participating in several clinical trials of novel medications to treat pulmonary arterial hypertension.

Education of patients and their families is also a high priority at the Pulmonary Hypertension Center. Our staff of doctors and nurses is readily available to educate and support our patients and their needs.

At the Pulmonary Hypertension Center at Columbia University Medical Center, we remain focused on our ultimate mission to find a cure for pulmonary arterial hypertension and are committed to providing comprehensive care to adults and children facing pulmonary hypertension.